Bayer stock weighs USD 2.2 billion Ohio plant plan

Published on 10/04/2026 at 14:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer stock was last at EUR 44.94 on October 2 after a 1.01 percent drop. Q2 2026 sales rose 2.2 percent to EUR 10.872 billion, while the average target is EUR 62.60.

Bauhaus-Stil Poster mit geometrischen Formen, Kreisen und dem Schriftzug PHARMA — Bayer AG (DE000BAY0017): Bauhaus-Poster mit geometrischen Formen, kräftigen Farben und dem großen Schriftzug PHARMA, Illustration mit AI erstellt.

Bayer (ISIN DE000BAY0017) stock was last at EUR 44.94 on Xetra on October 2, 2026, down 1.01 percent from the previous session. On the same date, Bayer announced a USD 2.2 billion investment in a new pharmaceutical manufacturing site in New Albany, Ohio.

Ohio investment reaches USD 2.2 billion

The planned facility is designed to serve patients in the United States and other markets. The multi-year project gives Bayer's Pharmaceuticals business a major capital commitment in the United States, linking the latest corporate announcement to manufacturing capacity rather than to a short-term product launch.

The announcement followed Bayer's second-quarter report, so the market has two separate signals to weigh: a large future investment and current operating growth. The first increases the strategic footprint, while the second provides the latest measurable performance checkpoint.

Q2 sales rose 2.2 percent

In Q2 2026, Bayer reported group sales of EUR 10.872 billion, up 2.2 percent on a currency and portfolio-adjusted basis, according to Bayer. EBITDA before special items increased 1.9 percent to EUR 2.144 billion in the same period.

The next operating test is already dated. Bayer lists November 3, 2026, for its Q3 2026 results and quarterly statement.

Analyst target stands at EUR 62.60

The September consensus published by finanzen.net was Buy from five analysts, with an average target of EUR 62.60, a low of EUR 60.00 and a high of EUR 70.00. The average target lies 39.25 percent above the EUR 44.94 reference price.

Deutsche Bank Research kept a Buy rating and a EUR 60.00 target on September 29, 2026, according to finanznachrichten.de. The bank expected Q3 operating sales growth of 1.3 percent but forecast a 10 percent decline in operating earnings because of favorable agricultural effects in the prior-year period.

Stock stays below the yearly high

Bayer stock was last at EUR 44.94 on Xetra at 5:35 p.m. CET on October 2, 2026. Its 52-week range was EUR 22.02 to EUR 53.92, placing the latest quote EUR 8.98 below the yearly high, while market capitalization stood at EUR 44.2 billion.